Treatment of psychiatric syndromes due to cerebrovascular disease

International Review of Psychiatry

Volumn 18, Issue 5, 2006, Pages 453-470

  Paranthaman, Raghu ^a   Baldwin, Robert C ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMITRIPTYLINE; AMPHETAMINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; DEXAMPHETAMINE; FLUOXETINE; IMIPRAMINE; METHYLPHENIDATE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; NIMODIPINE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PLACEBO; PSYCHOSTIMULANT AGENT; REBOXETINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ALZHEIMER DISEASE; ANOREXIA; ANXIETY DISORDER; APATHY; BIPOLAR MANIA; BLURRED VISION; CARDIOTOXICITY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; CONSTIPATION; DELIRIUM; DEPRESSION; DROWSINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG INHIBITION; ELECTROCONVULSIVE THERAPY; EMOTIONAL DISORDER; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTENSION; INSOMNIA; MULTIINFARCT DEMENTIA; NAUSEA; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIAPISM; PRIORITY JOURNAL; PSYCHOSIS; RESTLESSNESS; REVIEW; SCHIZOPHRENIA; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; TACHYCARDIA; TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN INJURY; URINE RETENTION; WEIGHT REDUCTION; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CEREBROVASCULAR DISORDERS; ELECTROCONVULSIVE THERAPY; HUMANS; MENTAL DISORDERS; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33750611000     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260600935462     Document Type: Review

References (100)

1. Alexopoulos, G. S., Meyers, B. S., Young, R. C., et al. (1997). 'Vascular depression' hypothesis. Archives of General Psychiatry, 54, 915-922.
2. Alexopoulos, G. S. (2001). 'The depression-executive dysfunction syndrome of late life:' A specific target for D3 agonists. American Journal of Geriatric Psychiatry, 9, 22-29.
3. Alexopoulos, G. S., Katz, I. R., Reynolds, C. F., Carpenter, D., & Docherty, J. P. (2001). The expert consensus guideline series: Pharmacotherapy of depressive disorders in older patients. A Postgraduate Medicine Special Report. (October): 1-86. Expert Knowledge Systems L.L.C, Minneapolis, MN: McGraw-Hill Healthcare Information Programs.
4. Alexopoulos, G. S., Kiosses, D. N., Klimstra, S., et al. (2002). Clinical presentation of the 'depression-executive dysfunction syndrome' of late life. American Journal of Geriatric Psychiatry, 10, 98-106.
5. Alexopoulos, G. S., Raue, P., & Arean, P. (2003). Problemsolving therapy versus supportive therapy in geriatric major depression with executive dysfunction. American Journal of Geriatric Psychiatry, 11, 46-52.
6. Allman, P. (1992). Drug treatment of emotionalism following brain damage. Journal of the Royal Society of Medicine, 85, 423-424.
7. American Psychiatric Association (APA) (1994). Diagnostic and Statistical Manual Version IV. Washington DC: American Psychiatric Association.
8. Andersen, G., Vestergaad, K., & Riis, J. O. (1993). Citalopram for post-stroke pathological crying. Lancet, 342, 837-839.
9. Andersen, G., Vestergaard, K., & Lauritzen, L. (1994). Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke, 25, 1099-1104.
10. Andersen, C. S., Hackett, M. L., House, A. O. (2004). Interventions for treating depression after stroke. Cochrane Database Systems Review 3. CD003689.
11. Astrom, M. (1996). Generalized anxiety disorder in stroke patients. A three-year longitudinal study. Stroke, 27, 270-275.
12. Baldwin, R. C., & O'Brien, J. (2002). Vascular basis of late-onset depressive disorder. British Journal of Psychiatry, 180, 157-160.
13. Baldwin, R. C., Anderson, D., Black, S., et al. (2003). Guideline for the management of late-life depression in primary care. International Journal of Geriatric Psychiatry, 18, 829-838.
14. Brodaty, H., Sachdev, P. S., Withall, A., Altendorf, A., Valenzuela, M. J., & Lorentz, L. (2005). Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke-the Sydney Stroke Study. Psychological Medicine, 35, 1707-1716.
15. Brown, K. W., Sloan, R. L., & Pentland, B. (1998). Fluoxetine as a treatment for post-stroke emotionalism. Acta Psychiatrica Scandinavica, 98, 455-458.
16. Burns, A., Russell, E., Stratton-Powell, H., et al. (1999). Sertraline in stroke-associated lability of mood. International Journal of Geriatric Psychiatry, 14, 681-685.
17. Burvill, P. W., Johnson, G. A., Jamrozik, K. D., et al. (1995). Prevalence of depression after stroke: The Perth Community Stroke Study. British Journal of Psychiatry, 166, 320-327.
18. Calvert, T., Knapp, P., & House, A. (1998). Psychological associations with emotionalism after stroke. Journal of Neurology Neurosurgery and Psychiatry, 65, 928-929.
19. Castillo, C. S., Starkstein, S. E., Fedoroff, J. P., et al. (1993). Generalized anxiety disorder after stroke. Journal of Nervous and Mental Disease, 181, 100-106.
20. Challman, T. D., & Lipsky, J. J. (2000). Methylphenidate: Its pharmacology and uses. Mayo Clinic Proceedings, 75, 711-721.
21. Couturier, J. L. (2005). Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: A systematic review and meta-analysis. Journal of Psychiatry and Neuroscience, 30, 83-90.
22. Currier, M. B., Murray, G. B., & Welch, C. C. (1992). Electroconvulsive therapy for post-stroke depressed geriatric patients. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 140-144.
23. Dahmen, N., Marx, J., Hopf, H. C., et al. (1999). Therapy of early post-stroke depression with venlafaxine: Safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial. Stroke, 30, 691-692.
24. Dennis, M., O'Rourke, S., Slattery, J., et al. (1997). Evaluation of a stroke family care worker: Results of a randomized controlled trial. British Medical Journal, 314, 1071-1076.
25. Eriksson, M., Asplund, K., Glader, E. L., et al. (2004). Self-reported depression and use of antidepressants after stroke: A national survey. Stroke, 35, 936-941.
26. Everson, S. A., Roberts, R. E., Goldberg, D. E., et al. (1998). Depressive symptoms and increased risk of stroke mortality over a 29-year period. Archives of Internal Medicine, 158, 1133-1138.
27. Fabre, I., Galinowski, A., Oppenheim, C., et al. (2004). Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: An open trial. International Journal of Geriatric Psychiatry, 19, 833-842.
28. Frazer, C. J., Christensen, H., & Griffiths, K. M. (2005). Effectiveness of treatments for depression in older people. Medical Journal of Australia, 182, 627-632.
29. Fruehwald, S., Gatterbauer, E., Rehak, P., et al. (2003). Early fluoxetine treatment of post-stroke depression-a three-month double-blind placebo-controlled study with an open-label longterm follow-up. Journal of Neurology, 250, 347-351.
30. Glassman, A. H., O'Connor, C. M., Califf, R. M., et al. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288, 701-709.
31. González- Torrecillas, J. L., Mendlewicz, J., & Lobo, A. (1995). Effects of early treatment of post-stroke depression on neuropsychological rehabilitation. International Psychogeriatrics, 7, 547-560.
32. Goodnick, P. J., & Hernandez, M. (2000). Treatment of depression in comorbid medical illness. Expert Opinion on Pharmacotherapy, 1, 1367-1384.
33. Grade, C., Redford, B., Chrostowski, J., et al. (1998). Methylphenidate in early post-stroke recovery: A double-blind, placebo-controlled study. Archives of Physical Medicine and Rehabilitation, 79, 1047-1050.
34. Gustafson, Y., Nilsson, I., Mattsson, M., et al. (1995). Epidemiology and treatment of post-stroke depression. Drugs & Aging, 7, 298-309.
35. Hasey, G. (2001). Transcranial magnetic stimulation in the treatment of mood disorder: A review and comparison with electroconvulsive therapy. Canadian Journal of Psychiatry, 46, 720-727.
36. Herrmann, N., Mamdani, M., & Lanctot, K. L. (2004). Atypical antipsychotics and risk of cerebrovascular accidents. American Journal of Psychiatry, 161, 1113-1115.
37. House, A., Dennis, M., Molyneux, A., et al. (1989). Emotionalism after stroke. British Medical Journal, 298, 991-994.
38. House, A. O., Hackett, M. L., Anderson, C. S., et al. (2004). Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Systems Review 2. CD003690.
39. Jorge, R. E., Robinson, R. G., Tateno, A., et al. (2004). Repetitive transcranial magnetic stimulation as treatment of post-stroke depression: A preliminary study. Biological Psychiatry, 55, 398-405.
40. Kim, J. S., & Choi-Kwon, S. (2000). Post-stroke depression and emotional incontinence: Correlation with lesion location. Neurology, 54, 1805-1810.
41. Kimura, M., Robinson, R. G., & Kosier, J. T. (2000). Treatment of cognitive impairment after poststroke depression: A double-blind treatment trial. Stroke, 31, 1482-1486.
42. Kimura, M., Kanetani, K., & Imai, R. (2002). Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression. International Clinical Psychopharmacology, 17, 121-125.
43. Kimura, M., Tateno, A., & Robinson, R. G. (2003). Treatment of post-stroke generalized anxiety disorder comorbid with poststroke depression: Merged analysis of nortriptyline trials. American Journal of Geriatric Psychiatry, 11, 320-327.
44. Knapp, P., Young, J., House, A., et al. (2000). Non-drug strategies to resolve psycho-social difficulties after stroke. Age & Ageing, 29, 23-30.
45. Kneebone, I. I., & Dunmore, E. (2000). Psychological management of post-stroke depression. British Journal of Clinical Psychology, 39, 53-65.
46. Kotila, M., Numminen, H., Waltimo, O., et al. (1998). Depression after stroke: Results of the FINNSTROKE Study. Stroke, 29, 368-372.
47. Lader, M. H., & Ancill, R. J. (1998). The treatment of generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder in the elderly. In J. C. Nelson (Ed.), Geriatric Psychopharmacology (pp. 367-380). New York: Marcel Dekker Inc.
48. Lazarus, L. W., Moberg, P. J., Langsley, P. R., et al. (1994). Methylphenidate and nortriptyline in the treatment of poststroke depression: A retrospective comparison. Archives of Physical Medicine and Rehabilitation, 75, 403-406.
49. Lee, M. S., Ham, B. J., Kee, B. S., et al. (2005). Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression. Current Medical Research and Opinion, 21, 1369-1375.
50. Levy, M. L., Cummings, J. L., Fairbanks, L. A., et al. (1998). Apathy is not depression. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 314-319.
51. Lincoln, N. B., Flannaghan, T., Sutcliffe, L., et al. (1997). Evaluation of cognitive behavioural treatment for depression after stroke: A pilot study. Clinical Rehabilitation, 11, 114-122.
52. Lincoln, N. B., & Flannaghan, T. (2003). Cognitive behavioral psychotherapy for depression following stroke: A randomized controlled trial. Stroke, 34, 111-115.
53. Lingham, V. R., Lazarus, L. W., Groves, L., et al. (1988). Methylphenidate in treating post-stroke depression. Journal of Clinical Psychiatry, 49, 151-153.
54. Lipsey, J. R., Robinson, R. G., Pearlson, G. D., et al. (1984). Nortriptyline treatment of post-stroke depression: A doubleblind study. Lancet, 1, 297-300.
55. Lopez-Ibor, J. J., & Conesa, A. (2004). A comparative study of milnacipran and imipramine in the treatment of major depressive disorder. Current Medical Research and Opinion, 20, 855-860.
56. Manes, F., Jorge, R., Morcuende, M., et al. (2001). A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. International Psychogeriatrics, 13, 225-231.
57. Marin, R. S. (1991). Apathy: A neuropsychiatric syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 3, 243-254.
58. Marin, R. S., Fogel, B. S., Hawkins, J., et al. (1995). Apathy: A treatable syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 23-30.
59. Masand, P., Murray, G. B., & Pickett, P. (1991). Psychostimulants in post-stroke depression. Journal of Neuropsychiatry and Clinical Neurosciences, 3, 23-27.
60. Morris, P., Hopwood, M., Maguire, K., et al. (2003). Blunted prolactin response to D-fenfluramine in post-stroke major depression. Journal of Affective Disorders, 76, 273-278.
61. Murray, G. B., Shea, V., & Conn, D. K. (1986). Electroconvulsive therapy for post-stroke depression. Journal of Clinical Psychiatry, 47, 258-260.
62. Murray, V., Von Arbin, M., Bartfai, A., et al. (2005). Doubleblind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. Journal of Clinical Psychiatry, 66, 708-716.
63. Narushima, K., Kosier, J. T., & Robinson, R. G. (2002). Preventing post-stroke depression: A 12-week double-blind randomized treatment trial and 21-month follow-up. Journal of Nervous and Mental Disease, 190, 296-303.
64. Niedermaier, N., Bohrer, E., Schulte, K., et al. (2004). Prevention and treatment of post-stroke depression with mirtazapine in patients with acute stroke. Journal of Clinical Psychiatry, 65, 1619-1623.
65. Ohkawa, S., Mori, E., & Yamadori, A. (1989). Treatment of pathological laughing with amitriptyline. Rinsho Shinkeigaku, 29, 1183-1185.
66. Palomaki, H., Kaste, M., Berg, A., et al. (1999). Prevention of post-stroke depression: 1-year randomized placebo controlled double blind trial of mianserin with 6-month follow-up after therapy. Journal of Neurology Neurosurgery and Psychiatry, 66, 490-494.
67. Parikh, R. M., Robinson, R. G., Lipsey, J. R., et al. (1990). The impact of post-stroke depression on recovery in activities of daily living over a 2-year follow-up. Archives of Neurology, 47, 785-789.
68. Parker, G. (2005). Beyond major depression. Psychological Medicine, 35, 467-474.
69. Rabins, P. V., Starkstein, S. E., & Robinson, R. G. (1991). Risk factors for developing atypical (schizophreniform) psychosis following stroke. Journal of Neuropsychiatry and Clinical Neurosciences, 3, 6-9.
70. Rampello, L., Chiechio, S., Nicoletti, G., et al. (2004). Prediction of the response to citalopram and reboxetine in poststroke depressed patients. Psychopharmacology, 173, 73-78.
71. Rasmussen, A., Lunde, M., Poulsen, D. L., et al. (2003). A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics, 44, 216-221.
72. Reding, M. J., Orto, L. A., Winter, S. W., et al. (1986). Antidepressant therapy after stroke. A double-blind trial. Archives of Neurology, 43, 763-765.
73. Reznik, I., Rosen, Y., & Rosen, B. (1999). An acute ischaemic event associated with the use of venlafaxine: A case report and proposed pathophysiological mechanisms. Journal of Psychopharmacology, 13, 193-195.
74. Robinson, R. G., Parikh, R. M., Lipsey, J. R., et al. (1993). Pathological laughing and crying following stroke: Validation of a measurement scale and a double-blind treatment study. American Journal of Psychiatry, 150, 286-293.
75. Robinson, R. G. (1997). Neuropsychiatric consequences of stroke. Annual Review of Medicine, 48, 217-229.
76. Robinson, R. G., Schultz, S. K., Castillo, C., et al. (2000). Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study. American Journal of Psychiatry, 157, 351-359.
77. Scates, A. C., & Doraiswamy, P. M. (2000). Reboxetine: A selective norepinephrine reuptake inhibitor for the treatment of depression. Annals of Pharmacotherapy, 34, 1302-1312.
78. Schiffer, R. B., Cash, J., & Herndon, R. M. (1983). Treatment of emotional lability with low-dosage tricyclic antidepressants. Psychosomatics, 24, 1094-1096.
79. Shulman, K. I. (2002). Mania and cerebrovascular disease. In E. Chui, D. Ames, C. Katona & M. Dunitz (Eds.), Vascular disease and affective disorders (pp. 235-244). London: Taylor & Francis.
80. Simpson, S., Baldwin, R. C., Jackson, A., et al. (1998). Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychological Medicine, 28, 1015-1026.
81. Smith, A. G., Montealegre-Orjuela, M., Douglas, J. E., et al. (2003). Venlafaxine for pathological crying after stroke. Journal of Clinical Psychiatry, 64, 731-732.
82. Spalletta, G., & Caltagirone, C. (2003a). Sertraline treatment of post-stroke major depression: An open study in patients with moderate to severe symptoms. Functional Neurology, 18, 227-232.
83. Spalletta, G., Guida, G., & Caltagirone, C. (2003b). Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance? Journal of Neurology, 250, 449-455.
84. Starkstein, S. E., Federoff, J. P., Price, T. R., et al. (1993). Apathy following cerebrovascular lesions. Stroke, 24, 1625-1630.
85. Steffens, D. C., & Krishnan, K. R. (1998). Structural neuroimaging and mood disorders: Recent findings, implications for classification, and future directions. Biological Psychiatry, 43, 705-712.
86. Tan, I., & Dorevitch, M. (1996). Emotional incontinence: A dramatic response to paroxetine. Australian and New Zealand Journal of Medicine, 26, 844.
87. Taragano, F. E., Bagnatti, P., & Allegri, R. F. (2005). A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of 'vascular depression.' International Psychogeriatrics, 17, 487-498.
88. Tew, Jr, JD, Mulsant, B. H., Haskett, R. F., et al. (1999). Acute efficacy of ECT in the treatment of major depression in the oldold. American Journal of Psychiatry, 156, 1865-1870.
89. Tiller, J. W. (1992). Post-stroke depression. Psychopharmacology, 106(Suppl), S130-133.
90. Towle, D., Lincoln, N. B., & Mayfield, L. M. (1989). Evaluation of social work on depression after stroke. Clinical Rehabilitation, 3, 89-96.
91. Udaka, F., Yamao, S., Nagata, H., et al. (1984). Pathologic laughing and crying treated with levodopa. Archives of Neurology, 41, 1095-1096.
92. Van Reekum, R., Stuss, D. T., & Ostrander, L. (2005). Apathy: Why care? Journal of Neuropsychiatry and Clinical Neurosciences, 17, 7-19.
93. Van Walraven, C., Mamdani, M. M., Wells, P. S., et al. (2001). Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: Retrospective cohort study. British Medical Journal, 323, 655-658.
94. Vataja, R., Pohjasvaara, T., Mantyla, R., et al. (2005). Depression-executive dysfunction syndrome in stroke patients. American Journal of Geriatric Psychiatry, 13, 99-107.
95. Wan, S. K., Seon, S. Ii, Min, J. K., et al. (2005). Mirtazapine treatment for pathological laughing and crying after stroke. Clinical Neuropharmacology, 28, 249-251.
96. Watanabe, M. D., Martin, E. M., Deleon, O. A., et al. (1995). Successful methylphenidate treatment of apathy after subcortical infarcts. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 502-504.
97. Wiart, L., Petit, H., Joseph, P. A., et al. (2000). Fluoxetine in early post-stroke depression: A double-blind placebo-controlled study. Stroke, 31, 1829-1832.
98. Wolf, J. K., Santana, H. B., & Thorpy, M. (1979). Treatment of 'emotional incontinence' with levodopa. Neurology, 29, 1435-1436.
99. Wylie, M. E., Mulsant, B. H., Pollock, B. G., et al. (1999). Age at onset in geriatric bipolar disorder. Effects on clinical presentation and treatment outcomes in an inpatient sample. American Journal of Geriatric Psychiatry, 7, 77-83.
100. Zhang, Y. X., Zhang, H. L., & Wang, H. (2005). Effects of buspirone hydrochloride on post-stroke affective disorder and neural function. Chinese Journal of Clinical Rehabilitation, 9(12), 8-9.